Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Contemporary Clinical Trials Communications|January 21, 2020
Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study)Anna Ozaki, Masato Yoneda, Takaomi Kessoku, et al.Contemporary Clinical Trials Communications|November 17, 2022
Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocolTsutomu Yoshihara, Takaomi Kessoku, Tomohiro Takatsu, et al.Scientific Reports|October 28, 2022
A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costsTakashi Kobayashi, Yuji Ogawa, Satoru Shinoda, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort studyYuya Seko, Kanji Yamaguchi, Toshihide Shima, et al.Hepatology Communications|October 30, 2023
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver diseaseMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2023
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver diseaseKouichi Miura, Hideki Hayashi, Yoshihiro Kamada, et al.Scientific Reports|December 10, 2021
A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumoursTsutomu Yoshihara, Mitomu Kioi, Junichi Baba, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2020
Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseKento Imajo, Yasushi Honda, Takashi Kobayashi, et al.BMJ Open|July 12, 2022
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa studyMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.Neurogastroenterology and Motility|October 7, 2024
Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label studyTsutomu Yoshihara, Takaomi Kessoku, Tomohiro Takatsu, et al.Pageof 9